Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index; 4 of the 19 sources its claims cite were checked for support.

Epinephrine-induced Insulin Resistance in Man

Open access
Deibert, David C., Defronzo, Ralph A. · 1980 · Journal of Clinical Investigation

Abstract

Endogenous release of epinephrine after stress as well as exogenous epinephrine infusion are known to result in impaired glucose tolerance. Previous studies of man and animals have demonstrated that this effect of epinephrine results from inhibition of insulin secretion and augmentation of hepatic glucose production. However, the effect of epinephrine on tissue sensitivity to insulin, and the relative contributions of peripheral vs. hepatic resistance to impaired insulin action, have not been defined. Nine young normal-weight subjects were studied with the insulin clamp technique. Plasma insulin was raised by approximately 100 muU/ml while plasma glucose concentration was maintained at basal levels by a variable glucose infusion. Under these conditions of euglycemia, the amount of glucose metabolized equals the glucose infusion rate and is a measure of tissue sensitivity to insulin. Subjects received four studies: (a) insulin (42.6 mU/m(2).min), (b) insulin plus epinephrine (0.05 mug/kg.min), (c) insulin plus epinephrine plus propranolol (1.43 mug/kg.min), and (d) insulin plus propranolol. During insulin administration alone, glucose metabolism averaged 5.49+/-0.58 mg/kg.min. When epinephrine was infused with insulin, glucose metabolism fell by 41% to 3.26 mg/kg.min (P < 0.001). After insulin alone, hepatic glucose production declined by 92% to 0.16+/-0.08 mg/kg.min. Addition of epinephrine was associated with a delayed and incomplete suppression of glucose production (P < 0.01) despite plasma insulin levels >100 muU/ml. When propranolol was administered with epinephrine, total glucose metabolism was restored to control values and hepatic glucose production suppressed normally. Propranolol alone had no effect on insulin-mediated glucose metabolism. These results indicate that epinephrine, acting primarily through a beta-adrenergic receptor, markedly impairs tissue sensitivity to an increase in plasma insulin levels, and that this effect results from both peripheral and hepatic resistance to the action of insulin.

Overview

CoChat Summary

TL;DR

In nine healthy young adults, epinephrine infusion during euglycemic hyperinsulinemia reduced insulin-mediated glucose metabolism by 41% and blunted insulin suppression of hepatic glucose production. Propranolol reversed both effects, indicating that epinephrine-induced insulin resistance is mediated primarily through β-adrenergic receptors and involves peripheral and hepatic tissues.

Key findings

  • During insulin clamp alone, total glucose metabolism averaged 5.49±0.58 mg/kg·min; adding epinephrine (0.05 μg/kg·min) reduced it by 41% to 3.26±0.24 mg/kg·min (P < 0.001).
  • Insulin alone suppressed endogenous glucose production by 92% to 0.16±0.08 mg/kg·min; epinephrine caused delayed and incomplete suppression (60–120 min: 0.73±0.18 vs. 0.16±0.08 mg/kg·min; P < 0.005), and during the first 20 min hepatic glucose production rose to 2.58±0.32 vs. 0.49±0.16 mg/kg·min.
  • Propranolol with epinephrine restored total glucose metabolism to 5.73±0.67 mg/kg·min, not significantly different from control, and blocked epinephrine’s hepatic effect; propranolol alone had no significant effect (5.28±0.42 mg/kg·min).
  • Epinephrine also potentiated the insulin-induced decline in all plasma amino acids except alanine by ~15–20% greater than insulin alone; propranolol reversed this effect.

Methods

  • Design: euglycemic insulin clamp with [3-3H]glucose in nine healthy volunteers (five females, four males; age 23–30 yr, mean 26±1 yr; 90–112% ideal body weight, mean 99±2%), each serving as their own control, studied postabsorptive after a 12-h overnight fast.
  • Four protocols: insulin alone (42.6 mU/m²·min), insulin plus epinephrine (0.05 μg/kg·min), insulin plus epinephrine plus propranolol, and insulin plus propranolol; plasma glucose was maintained at basal levels while plasma insulin was raised to steady-state ~132–135 μU/ml.
  • Analysis: under steady-state euglycemia, glucose infusion rate equals tissue sensitivity to insulin; endogenous glucose production was calculated using tritiated glucose; data are mean±SEM with paired Student’s t tests.

Limitations

  • Stated: smaller epinephrine doses, as might be expected in mild to moderate stress, were not examined; no α-adrenergic blocker was administered, so a contribution of α-adrenergic receptors to insulin antagonism cannot be excluded.
  • Evident from the text: the sample was small (n=9), young, healthy, and normal-weight, and the clamp period was 2 h; propranolol co-infusion raised plasma epinephrine to 1,441±96 vs. 736±23 pg/ml with epinephrine alone, though the authors state this does not alter interpretation.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1172/jci109718

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

2 Valid · 1 Not valid · 4 Not checked · 28 Own results and interpretations

16 more claims

Create a free account to see all 35 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 9
  • Probably not a substantial claim. 7

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Self-check results appear here once an independent check has confirmed them.

Cited works that were retracted

Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.

1 of 1

Citations

Cites

1 retracted

Show all 21 references

Cited by

See all 557

Metadata

Authors
Deibert, D. C., & Defronzo, R. A.
Affiliations
Yale University (US)
Venue
Journal of Clinical Investigation
Published
1980-03-01
Volume
65
Issue
3
Pages
717-721
ISSN
0021-9738 (ISSN-L)
OpenAlex
W2064971980
Cited by
557
References
21
Citations by year
2026: 12 · 2025: 5 · 2024: 9 · 2023: 9 · 2022: 5 · 2021: 8 · 2020: 14 · 2019: 10 · 2018: 9 · 2017: 10 · 2016: 10 · 2015: 16 · 2014: 21 · 2013: 10 · 2012: 18
FWCI
11.85
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
epinephrine, insulin resistance, beta-adrenergic receptors, propranolol, hepatic glucose production, glucose metabolism, insulin secretion, hyperinsulinemic-euglycemic clamp, peripheral insulin sensitivity, stress hyperglycemia
MeSH terms
Adult, Amino Acids, Blood Glucose, Drug Resistance, Epinephrine, Female, Glucagon, Glucose, Humans, Insulin, Liver, Male, Propranolol, Receptors, Adrenergic, beta

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Epinephrine-induced Insulin Resistance in Man. https://app.cochat.ai/papers/10.1172/jci109718
The paper
Deibert, D. C., & Defronzo, R. A. (1980). Epinephrine-induced Insulin Resistance in Man. Journal of Clinical Investigation. https://doi.org/10.1172/jci109718

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.